Effect of Carvedilol on Survival in Severe Chronic Heart Failure

10.1056/NEJM199605233342101

10.1016/S0140-6736(98)11181-9

10.1016/S0140-6736(99)04440-2

10.1001/jama.283.10.1295

Domanski MJ, 2000, J Am Coll Cardiol, 35, 202A

Lechat P, 2000, Eur Heart J, 21, 297

10.1161/01.CIR.80.3.551

Sackner-Bernstein J, 1995, Circulation, 92, I

10.1016/S0033-0620(98)80030-3

Dandona P, 2000, Circulation, 101, 122, 10.1161/01.CIR.101.2.122

Qin F, 2000, J Am Coll Cardiol, 35, 168A

10.1006/jmcc.1997.0582

Kaddoura S, 1996, Circulation, 93, 2068, 10.1161/01.CIR.93.11.2068

10.1016/S0008-6363(98)00166-7

10.1016/0735-1097(95)00520-X

10.1016/S0735-1097(98)00101-6

10.2307/2281868

Cox DR, 1972, J R Stat Soc [B], 34, 187

10.1056/NEJM199610103351504

10.2307/2530245

10.2307/2336502

10.1016/S0002-9149(00)01114-0

10.1056/NEJM198706043162301

10.1056/NEJM199909023411001

10.1016/0002-9343(63)90118-9

10.1016/0140-6736(90)91517-E

Weyl JD, 1985, Arch Int Pharmacodyn Ther, 275, 4

Willette RN, 1999, J Pharmacol Exp Ther, 289, 48

10.1097/00005344-199006000-00014

Grupp IL, 1998, Am J Physiol, 275, H1338

Downing SE, 1983, Circ Res, 52, 471, 10.1161/01.RES.52.4.471

10.1056/NEJM199108013250501